Literature DB >> 19719236

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation.

Michael J Gorczynski1, Pamela K Smitherman, Taro E Akiyama, Harold B Wood, Joel P Berger, S Bruce King, Charles S Morrow.   

Abstract

Nitroalkene fatty acids are potent endogenous ligand activators of PPARgamma-dependent transcription. Previous studies with the naturally occurring regioisomers of nitrolinoleic acid revealed that the isomers are not equivalent with respect to PPARgamma activation. To gain further insight into the structure-activity relationships between nitroalkenes and PPARgamma, we examined additional naturally occurring nitroalkenes derived from oleic acid, 9-nitrooleic acid (E-9-NO2-18:1 [1]) and 10-nitrooleic acid (E-10-NO2-18:1 [2]), and several synthetic nitrated enoic fatty acids of variable carbon chain length, double bonds, and nitration site. At submicromolar concentrations, E-12-NO2 derivatives were considerably more potent than isomers nitrated at carbons 5, 6, 9, 10, and 13, and chain length (16 versus 18) or number of double bonds (1 versus 2) was of little consequence for PPARgamma activation. Interestingly, at higher concentrations (>2 microM) the nitrated enoic fatty acids (E-9-NO2-18:1 [1], E-9-NO2-16:1 [3], E-10-NO2-18:1 [2], and E-12-NO2-18:1 [7]) deviated significantly from the saturable pattern of PPARgamma activation observed for nitrated 1,4-dienoic fatty acids (E-9-NO2-18:2, E-10-NO2-18:2, E-12-NO2-18:2, and E-13-NO2-18:2).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719236      PMCID: PMC2741172          DOI: 10.1021/jm900326c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

Review 1.  Dietary chemopreventive compounds and ARE/EpRE signaling.

Authors:  Chi Chen; A-N Tony Kong
Journal:  Free Radic Biol Med       Date:  2004-06-15       Impact factor: 7.376

2.  Role of mitogen-activated protein kinases in phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.

Authors:  Dong Xiao; Sunga Choi; Yong J Lee; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2005-07       Impact factor: 4.784

3.  L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.

Authors:  A Elbrecht; Y Chen; A Adams; J Berger; P Griffin; T Klatt; B Zhang; J Menke; G Zhou; R G Smith; D E Moller
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

4.  Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.

Authors:  Francisco J Schopfer; Yiming Lin; Paul R S Baker; Taixing Cui; Minerva Garcia-Barrio; Jifeng Zhang; Kai Chen; Yuqing E Chen; Bruce A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

5.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 6.  A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway.

Authors:  Yuesheng Zhang; Gary B Gordon
Journal:  Mol Cancer Ther       Date:  2004-07       Impact factor: 6.261

7.  Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation.

Authors:  Paul R S Baker; Francisco J Schopfer; Scott Sweeney; Bruce A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

8.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

Authors:  B M Forman; P Tontonoz; J Chen; R P Brun; B M Spiegelman; R M Evans
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

9.  Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.

Authors:  Joel P Berger; Ann E Petro; Karen L Macnaul; Linda J Kelly; Bei B Zhang; Karen Richards; Alex Elbrecht; Bruce A Johnson; Gaochao Zhou; Thomas W Doebber; Chhabi Biswas; Mona Parikh; Neelam Sharma; Michael R Tanen; G Marie Thompson; John Ventre; Alan D Adams; Ralph Mosley; Richard S Surwit; David E Moller
Journal:  Mol Endocrinol       Date:  2003-01-16

10.  Structural basis for the activation of PPARgamma by oxidized fatty acids.

Authors:  Toshimasa Itoh; Louise Fairall; Kush Amin; Yuka Inaba; Attila Szanto; Balint L Balint; Laszlo Nagy; Keiko Yamamoto; John W R Schwabe
Journal:  Nat Struct Mol Biol       Date:  2008-09       Impact factor: 15.369

View more
  15 in total

1.  Gas-phase fragmentation analysis of nitro-fatty acids.

Authors:  Gustavo Bonacci; Eliana K Asciutto; Steven R Woodcock; Sonia R Salvatore; Bruce A Freeman; Francisco J Schopfer
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-13       Impact factor: 3.109

2.  Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potencies.

Authors:  Darcy J P Bates; Pamela K Smitherman; Alan J Townsend; S Bruce King; Charles S Morrow
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

Review 3.  Formation and signaling actions of electrophilic lipids.

Authors:  Francisco J Schopfer; Chiara Cipollina; Bruce A Freeman
Journal:  Chem Rev       Date:  2011-09-20       Impact factor: 60.622

4.  Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism.

Authors:  Emilia Kansanen; Gustavo Bonacci; Francisco J Schopfer; Suvi M Kuosmanen; Kit I Tong; Hanna Leinonen; Steven R Woodcock; Masayuki Yamamoto; Carsten Carlberg; Seppo Ylä-Herttuala; Bruce A Freeman; Anna-Liisa Levonen
Journal:  J Biol Chem       Date:  2011-02-25       Impact factor: 5.157

5.  Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine.

Authors:  Sonia R Salvatore; Dario A Vitturi; Paul R S Baker; Gustavo Bonacci; Jeffrey R Koenitzer; Steven R Woodcock; Bruce A Freeman; Francisco J Schopfer
Journal:  J Lipid Res       Date:  2013-04-25       Impact factor: 5.922

Review 6.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

7.  Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase.

Authors:  Dario A Vitturi; Chen-Shan Chen; Steven R Woodcock; Sonia R Salvatore; Gustavo Bonacci; Jeffrey R Koenitzer; Nicolas A Stewart; Nobunao Wakabayashi; Thomas W Kensler; Bruce A Freeman; Francisco J Schopfer
Journal:  J Biol Chem       Date:  2013-07-22       Impact factor: 5.157

8.  Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.

Authors:  Marsha P Cole; Tanja K Rudolph; Nicholas K H Khoo; Uche N Motanya; Franca Golin-Bisello; Jeffrey W Wertz; Francisco J Schopfer; Volker Rudolph; Steven R Woodcock; Subhashini Bolisetty; Muhammad S Ali; Jifeng Zhang; Y Eugene Chen; Anupam Agarwal; Bruce A Freeman; Philip M Bauer
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

Review 9.  Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury.

Authors:  Choongho Lee
Journal:  Oxid Med Cell Longev       Date:  2017-08-27       Impact factor: 6.543

Review 10.  The discovery of nitro-fatty acids as products of metabolic and inflammatory reactions and mediators of adaptive cell signaling.

Authors:  Bruce A Freeman; Valerie B O'Donnell; Francisco J Schopfer
Journal:  Nitric Oxide       Date:  2018-05-06       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.